Stacy M Fischer1, Lilia Cervantes2, Regina M Fink3, Jean S Kutner4. 1. Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA. Electronic address: stacy.fischer@ucdenver.edu. 2. Denver Health and Hospital Authority, Denver, Colorado, USA. 3. University of Colorado Hospital, Aurora, Colorado, USA; University of Colorado College of Nursing, Aurora, Colorado, USA. 4. Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Abstract
CONTEXT: Latinos experience significant health disparities at the end of life compared with non-Latinos. OBJECTIVES: To determine the feasibility of a patient navigator intervention to improve palliative care outcomes for Latino adults with serious illness. METHODS: This was a pilot randomized controlled trial that included 64 Latino adults with life-limiting illness randomized to an intervention or a control group. All participants received a packet of linguistically matched materials on palliative care. In addition, intervention participants received up to five home visits from the bilingual, bicultural patient navigator. Visits focused on addressing barriers to palliative care through education, activation, and culturally tailored messaging. Outcomes included feasibility and advance care planning rates, documentation of pain management discussions in the medical record, and hospice utilization. RESULTS: Of the 32 patients randomized to the intervention arm, 81% had at least one home visit (range 1-5) with the patient navigator. Overall, advance care planning was higher in the intervention group (47% [n = 15] vs. 25% [n = 8], P = 0.06), and 79% of intervention participants had a discussion about pain management documented in their medical record vs. 54% of control patients (P = 0.05). Hospice enrollment between the two groups (n = 18 decedents) was similar (n = 7 intervention vs. n = 6 control); length of stay in the intervention group was 36.4 ± 51.6 vs. 19.7 ± 33.6 days for control patients (P = 0.39). CONCLUSION: A culturally tailored patient navigator intervention was feasible and suggests improved palliative care outcomes for Latinos facing advanced medical illness, justifying a fully powered randomized controlled trial.
RCT Entities:
CONTEXT: Latinos experience significant health disparities at the end of life compared with non-Latinos. OBJECTIVES: To determine the feasibility of a patient navigator intervention to improve palliative care outcomes for Latino adults with serious illness. METHODS: This was a pilot randomized controlled trial that included 64 Latino adults with life-limiting illness randomized to an intervention or a control group. All participants received a packet of linguistically matched materials on palliative care. In addition, intervention participants received up to five home visits from the bilingual, bicultural patient navigator. Visits focused on addressing barriers to palliative care through education, activation, and culturally tailored messaging. Outcomes included feasibility and advance care planning rates, documentation of pain management discussions in the medical record, and hospice utilization. RESULTS: Of the 32 patients randomized to the intervention arm, 81% had at least one home visit (range 1-5) with the patient navigator. Overall, advance care planning was higher in the intervention group (47% [n = 15] vs. 25% [n = 8], P = 0.06), and 79% of intervention participants had a discussion about pain management documented in their medical record vs. 54% of control patients (P = 0.05). Hospice enrollment between the two groups (n = 18 decedents) was similar (n = 7 intervention vs. n = 6 control); length of stay in the intervention group was 36.4 ± 51.6 vs. 19.7 ± 33.6 days for control patients (P = 0.39). CONCLUSION: A culturally tailored patient navigator intervention was feasible and suggests improved palliative care outcomes for Latinos facing advanced medical illness, justifying a fully powered randomized controlled trial.
Authors: Kristen J Wells; Tracy A Battaglia; Donald J Dudley; Roland Garcia; Amanda Greene; Elizabeth Calhoun; Jeanne S Mandelblatt; Electra D Paskett; Peter C Raich Journal: Cancer Date: 2008-10-15 Impact factor: 6.860
Authors: Elizabeth A Calhoun; Elizabeth M Whitley; Angelina Esparza; Elizabeth Ness; Amanda Greene; Roland Garcia; Patricia A Valverde Journal: Health Promot Pract Date: 2008-12-30
Authors: Liana D Castel; Benjamin R Saville; Venita Depuy; Paul A Godley; Katherine E Hartmann; Amy P Abernethy Journal: Cancer Date: 2008-01-01 Impact factor: 6.860
Authors: Alexander K Smith; Ellen P McCarthy; Elizabeth Paulk; Tracy A Balboni; Paul K Maciejewski; Susan D Block; Holly G Prigerson Journal: J Clin Oncol Date: 2008-09-01 Impact factor: 44.544
Authors: Manali I Patel; Vandana Sundaram; Manisha Desai; Vyjeyanthi S Periyakoil; James S Kahn; Jay Bhattacharya; Steven M Asch; Arnold Milstein; M Kate Bundorf Journal: JAMA Oncol Date: 2018-10-01 Impact factor: 31.777
Authors: Lilia Cervantes; Michel Chonchol; Romana Hasnain-Wynia; John F Steiner; Edward Havranek; Madelyne Hull; John Rice; Jessica Kendrick; Xochilt Alamillo; Claudia Camacho; Stacy Fischer Journal: J Palliat Med Date: 2019-01-31 Impact factor: 2.947
Authors: Jennifer Freytag; Richard L Street; Deborah E Barnes; Ying Shi; Aiesha M Volow; Janet K Shim; Stewart C Alexander; Rebecca L Sudore Journal: J Am Geriatr Soc Date: 2020-03-10 Impact factor: 5.562